近期非小细胞肺癌免疫疗法的临床试验。 - Suppr

Suppr

超能文献

Recent clinical trials of immunotherapy in non-small-cell lung cancer.

作者信息

Gkolfinopoulos Stavros, Mountzios Giannis

机构信息

Medical Oncology Department, BOC Oncology Center, Nicosia 2006, Cyprus.

2nd Medical Oncology Department, Henry Dunant Hospital Center, Athens 11526, Greece.

出版信息

Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.

DOI:10.2217/imt-2019-0021

PMID:30860438

Abstract

摘要

相似文献

Recent clinical trials of immunotherapy in non-small-cell lung cancer.

Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.

Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.

Am J Ther. 2018 May/Jun;25(3):e349-e356. doi: 10.1097/MJT.0000000000000686.

Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?

Curr Probl Cancer. 2019 Feb;43(1):43-53. doi: 10.1016/j.currproblcancer.2018.07.008. Epub 2018 Aug 4.

[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].

Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.

Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?

Immunotherapy. 2019 Sep;11(13):1149-1160. doi: 10.2217/imt-2019-0071. Epub 2019 Jul 30.

Immune Checkpoint Inhibitors in Lung Cancer and Melanoma.

Semin Oncol Nurs. 2019 Oct;35(5):150932. doi: 10.1016/j.soncn.2019.08.011. Epub 2019 Sep 25.

The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.

Future Oncol. 2018 Feb;14(3):191-194. doi: 10.2217/fon-2017-0124. Epub 2018 Jan 16.

Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.

Semin Oncol. 2015 Oct;42 Suppl 2:S11-8. doi: 10.1053/j.seminoncol.2015.09.019. Epub 2015 Sep 11.

Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.

Curr Opin Oncol. 2018 Mar;30(2):98-104. doi: 10.1097/CCO.0000000000000434.

[Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].

Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):87-91. doi: 10.3760/cma.j.issn.1001-0939.2020.02.004.

引用本文的文献

The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential.

Pharmaceutics. 2024 Dec 26;17(1):22. doi: 10.3390/pharmaceutics17010022.

The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment.

Front Oncol. 2023 Apr 27;13:1153319. doi: 10.3389/fonc.2023.1153319. eCollection 2023.

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with mutation.

Transl Cancer Res. 2021 Sep;10(9):3963-3978. doi: 10.21037/tcr-21-565.

Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy.

Cancers (Basel). 2020 Jun 18;12(6):1609. doi: 10.3390/cancers12061609.

Current Perspectives in Cancer Immunotherapy.

Cancers (Basel). 2019 Sep 30;11(10):1472. doi: 10.3390/cancers11101472.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Recent clinical trials of immunotherapy in non-small-cell lung cancer.

作者信息

Gkolfinopoulos Stavros, Mountzios Giannis

机构信息

Medical Oncology Department, BOC Oncology Center, Nicosia 2006, Cyprus.

2nd Medical Oncology Department, Henry Dunant Hospital Center, Athens 11526, Greece.

出版信息

Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.

DOI:10.2217/imt-2019-0021

PMID:30860438

Abstract

摘要

相似文献

Recent clinical trials of immunotherapy in non-small-cell lung cancer.

Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.

Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.

Am J Ther. 2018 May/Jun;25(3):e349-e356. doi: 10.1097/MJT.0000000000000686.

Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?

Curr Probl Cancer. 2019 Feb;43(1):43-53. doi: 10.1016/j.currproblcancer.2018.07.008. Epub 2018 Aug 4.

[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].

Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.

Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?

Immunotherapy. 2019 Sep;11(13):1149-1160. doi: 10.2217/imt-2019-0071. Epub 2019 Jul 30.

Immune Checkpoint Inhibitors in Lung Cancer and Melanoma.

Semin Oncol Nurs. 2019 Oct;35(5):150932. doi: 10.1016/j.soncn.2019.08.011. Epub 2019 Sep 25.

The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.

Future Oncol. 2018 Feb;14(3):191-194. doi: 10.2217/fon-2017-0124. Epub 2018 Jan 16.

Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.

Semin Oncol. 2015 Oct;42 Suppl 2:S11-8. doi: 10.1053/j.seminoncol.2015.09.019. Epub 2015 Sep 11.

Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.

Curr Opin Oncol. 2018 Mar;30(2):98-104. doi: 10.1097/CCO.0000000000000434.

[Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].

Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):87-91. doi: 10.3760/cma.j.issn.1001-0939.2020.02.004.

引用本文的文献

The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential.

Pharmaceutics. 2024 Dec 26;17(1):22. doi: 10.3390/pharmaceutics17010022.

The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment.

Front Oncol. 2023 Apr 27;13:1153319. doi: 10.3389/fonc.2023.1153319. eCollection 2023.

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with mutation.

Transl Cancer Res. 2021 Sep;10(9):3963-3978. doi: 10.21037/tcr-21-565.

Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy.

Cancers (Basel). 2020 Jun 18;12(6):1609. doi: 10.3390/cancers12061609.

Current Perspectives in Cancer Immunotherapy.

Cancers (Basel). 2019 Sep 30;11(10):1472. doi: 10.3390/cancers11101472.